Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x

WEST PHARMACEUTICAL Aktie

 >WEST PHARMA Aktienkurs 
187.475 EUR    (Tradegate)
Ask: 187.8 EUR / 79 Stück
Bid: 187.15 EUR / 80 Stück
Tagesumsatz: 0 Stück
Realtime Kurs von 8 bis 22 Uhr!
WEST PHARMA Aktie über LYNX handeln
>WEST PHARMA Performance
1 Woche: -3,9%
1 Monat: -2,2%
3 Monate: -10,3%
6 Monate: -39,7%
1 Jahr: -38,9%
laufendes Jahr: -41,1%
>WEST PHARMACEUTICAL Aktie
Name:  WEST PHARMACEUTICAL SERVICES
Land:  USA
Sektor:  Gesundheit
ISIN/ Wkn:  US9553061055 / 864330
Symbol/ Ticker:  WPS (Frankfurt) / WST (NYSE)
Kürzel:  FRA:WPS, ETR:WPS, WPS:GR, NYSE:WST
Index:  S&P500
Webseite:  https://www.westpharma.co..
Marktkapitalisierung:  13750 Mio. EUR
Umsatz:  2510.8 Mio. EUR
EBITDA:  654.97 Mio. EUR
Gewinn je Aktie:  4.762 EUR
Schulden:  266.14 Mio. EUR
Liquide Mittel:  349.95 Mio. EUR
Umsatz-/ Gewinnwachstum:  0.4% / -22.1%
KGV/ KGV lG:  34.99 / 36.63
KUV/ KBV/ PEG:  5.65 / 5.97 / 3.74
Gewinnm./ Eigenkapitalr.:  16.13% / 17.42%
Dividende je Aktie:  0.769 EUR
Dividendenrendite/ -schätzung:  0.4% / 0.39%
Div. Historie:  30.04.25 - 0.18438€
07.02.25 - 0.20223€
>weitere anzeigen...
Insiderhandel:  -
Suchwörter:  WEST PHARMACEUTICAL, WEST PHARMA, WEST PHARMACEUTICALS
Letzte Datenerhebung:  22.06.25
>WEST PHARMA Eigentümer
Aktien: 71.85 Mio. St.
f.h. Aktien: 71.33 Mio. St.
Insider Eigner: 0.61%
Instit. Eigner: 97.95%
>WEST PHARMA Peer Group

 
20.06.25 - 23:01
WST Deadline: WST Investors Have Opportunity to West Pharmaceutical Services, Inc. Securities Fraud Lawsuit (PR Newswire)
 
NEW YORK, June 20, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of West Pharmaceutical Services, Inc. (NYSE: WST) between February 16, 2023 and February 12, 2025, both dates inclusive (the "Class Period"), of the important......
20.06.25 - 21:45
West Pharmaceutical Services, Inc. (WST), Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit (PR Newswire)
 
LOS ANGELES, June 20, 2025 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with losses related to West Pharmaceutical Services, Inc. ("West" or the "Company") (NYSE: WST) have opportunity to lead the securities fraud class action lawsuit. IF YOU ARE AN INVESTOR......
20.06.25 - 17:48
Faruqi & Faruqi Reminds West Pharmaceuticals Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of July 7, 2025 - WST (PR Newswire)
 
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In West To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in West between February 16, 2023, and February 12, 2025 and would like to......
20.06.25 - 15:01
West Pharmaceutical Services, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - WST (PR Newswire)
 
NEW YORK, June 20, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in West Pharmaceutical Services, Inc. ("West Pharmaceutical Services, Inc." or the "Company") (NYSE: WST) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf......
19.06.25 - 15:03
The Gross Law Firm Reminds West Pharmaceutical Services, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of July 7, 2025 - WST (PR Newswire)
 
NEW YORK, June 19, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of West Pharmaceutical Services, Inc. (NYSE: WST). Shareholders who purchased shares of WST during the class period listed are encouraged to contact the firm regarding possible lead......
17.06.25 - 18:01
West Pharmaceutical Services, Inc. (WST) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit (PR Newswire)
 
BENSALEM, Pa., June 17, 2025 /PRNewswire/ -- The Law Offices of Howard G. Smith announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against West Pharmaceutical Services, Inc. ("West" or the "Company") (NYSE: WST). IF YOU ARE......
17.06.25 - 14:42
Is West Pharmaceutical Services Stock Underperforming the Nasdaq? (Barchart)
 
While West Pharmaceutical Services has underperformed the broader Nasdaq Composite over the past year, analysts remain confident in its long-term growth prospects, citing strong fundamentals and innovation-driven......
17.06.25 - 11:45
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of West Pharmaceutical Services, Inc.(WST) Shareholders (PR Newswire)
 
NEW YORK, June 17, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in West Pharmaceutical Services, Inc. ("West Pharmaceutical Services, Inc." or the "Company") (NYSE: WST) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf......
16.06.25 - 11:48
The Gross Law Firm Reminds West Pharmaceutical Services, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of July 7, 2025 - WST (PR Newswire)
 
NEW YORK, June 16, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of West Pharmaceutical Services, Inc. (NYSE: WST). Shareholders who purchased shares of WST during the class period listed are encouraged to contact the firm regarding possible lead......
15.06.25 - 23:01
WST Deadline: WST Investors with Losses in Excess of $100K Have Opportunity to West Pharmaceutical Services, Inc. Securities Fraud Lawsuit (PR Newswire)
 
NEW YORK, June 15, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of West Pharmaceutical Services, Inc. (NYSE: WST) between February 16, 2023 and February 12, 2025, both dates inclusive (the "Class Period"), of the important......
15.06.25 - 16:36
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of West Pharmaceutical Services (PR Newswire)
 
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In West To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $100,000 in West between February 16, 2023, and February 12, 2025......
13.06.25 - 11:45
Investors in West Pharmaceutical Services, Inc. Should Contact Levi & Korsinsky Before July 7, 2025 to Discuss Your Rights - WST (PR Newswire)
 
NEW YORK, June 13, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in West Pharmaceutical Services, Inc. ("West Pharmaceutical Services, Inc." or the "Company") (NYSE: WST) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf......
12.06.25 - 11:45
West Pharmaceutical Services, Inc. Securities Fraud Class Action Lawsuit Pending: Contact The Gross Law Firm Before July 7, 2025 to Discuss Your Rights - WST (PR Newswire)
 
NEW YORK, June 12, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of West Pharmaceutical Services, Inc. (NYSE: WST). Shareholders who purchased shares of WST during the class period listed are encouraged to contact the firm regarding possible lead......
11.06.25 - 21:54
West Pharmaceutical Services, Inc. (WST) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit (PR Newswire)
 
LOS ANGELES, June 11, 2025 /PRNewswire/ -- Glancy Prongay & Murray LLP announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against West Pharmaceutical Services, Inc. ("West" or the "Company") (NYSE: WST). IF YOU SUFFERED A LOSS ON YOUR......
10.06.25 - 20:33
WST Investors Have Opportunity to West Pharmaceutical Services, Inc. Securities Fraud Lawsuit (PR Newswire)
 
NEW YORK, June 10, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of West Pharmaceutical Services, Inc. (NYSE: WST) between February 16, 2023 and February 12, 2025, both dates inclusive (the "Class Period"), of the important......
10.06.25 - 17:30
Wall Street Analysts Believe West Pharmaceutical (WST) Could Rally 26.92%: Here′s is How to Trade (Zacks)
 
The mean of analysts' price targets for West Pharmaceutical (WST) points to a 26.9% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock....
10.06.25 - 16:12
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of West Pharmaceutical Services (PR Newswire)
 
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In West To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in West between February 16, 2023, and February 12, 2025 and would like to......
10.06.25 - 11:45
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of July 7, 2025 in West Pharmaceutical Services, Inc. Lawsuit - WST (PR Newswire)
 
NEW YORK, June 10, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in West Pharmaceutical Services, Inc. ("West Pharmaceutical Services, Inc." or the "Company") (NYSE: WST) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf......
09.06.25 - 11:46
The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of July 7, 2025 in West Pharmaceutical Services, Inc. Lawsuit - WST (PR Newswire)
 
NEW YORK, June 9, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of West Pharmaceutical Services, Inc. (NYSE: WST). Shareholders who purchased shares of WST during the class period listed are encouraged to contact the firm regarding possible lead......
07.06.25 - 16:01
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST (PR Newswire)
 
NEW YORK, June 7, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against West Pharmaceutical Services, Inc. ("West" or the "Company") (NYSE: WST). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or......
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Ein dummer Bodybuilder redet Maskulatur. - Dr. Fritz P. Rinnhofer
Partner:    >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!